Cargando…
Sublingual Immunization with Chimeric C1q/CD40 Ligand/HIV Virus-like Particles Induces Strong Mucosal Immune Responses against HIV
Development of a vaccine that can elicit robust HIV specific antibody responses in the mucosal compartments is desired for effective prevention of HIV via sexual transmission. However, the current mucosal vaccines have either poor immunogenicity when administered orally or invite safety concerns whe...
Autores principales: | Liu, Dongliang, Zhang, Sheng, Poteet, Ethan, Marin-Muller, Christian, Chen, Changyi, Yao, Qizhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618657/ https://www.ncbi.nlm.nih.gov/pubmed/34835167 http://dx.doi.org/10.3390/vaccines9111236 |
Ejemplares similares
-
CTLA-4 Blockade, during HIV Virus-Like Particles Immunization, Alters HIV-Specific B-Cell Responses
por: Lewis, Phoebe E., et al.
Publicado: (2020) -
A Novel Prime and Boost Regimen of HIV Virus-Like Particles with TLR4 Adjuvant MPLA Induces Th1 Oriented Immune Responses against HIV
por: Poteet, Ethan, et al.
Publicado: (2015) -
Mesothelin and TGF-α predict pancreatic cancer cell sensitivity to EGFR inhibitors and effective combination treatment with trametinib
por: Poteet, Ethan, et al.
Publicado: (2019) -
Mucosal Immunity and Sublingual Immunotherapy in Respiratory Disorders
por: Bahceciler, Nerin N.
Publicado: (2012) -
Sublingual Delivery of Vaccines for the Induction of Mucosal Immunity
por: Shim, Byoung-Shik, et al.
Publicado: (2013)